CLINICAL TRIALS PROFILE FOR JENTADUETO XR
✉ Email this page to a colleague
All Clinical Trials for JENTADUETO XR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01947153 ↗ | Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®. | Completed | Boehringer Ingelheim | Phase 1 | 2013-11-01 | The objective of the current study is to demonstrate bioequivalence of two 2.5 mg linagliptin/500 mg metformin fixed dose combination tablets compared to the free combination of the linagliptin 5 mg and metformin 1000 mg in healthy male and female volunteers. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for JENTADUETO XR
Condition Name
Clinical Trial Locations for JENTADUETO XR
Clinical Trial Progress for JENTADUETO XR
Clinical Trial Phase
Clinical Trial Sponsors for JENTADUETO XR
Sponsor Name